Research points to differences in appetite control and energy expenditure. It is important for obese people not to hold themselves responsible for their condition. Obese people should be evaluated for medical consequences of their obesity. Motivated persons are encourage to enter medically supervised treatment programs that use a multidisciplinary approach to weight loss. Many people are tempted by ads that use celebrities to tout liquid fasting diets for weight loss. Ads claim quick and easy weight loss with use of such products. Very obese patients may be referred to these types of diets. Their diets are carefully supervised by their healthcare provider. Fasting diets for weight loss may be right for obese persons who have serious weight-related medical problems. Rapid weight loss is the primary advantage of using these diets. This may be helpful in motivating the individual to continue with the program. This may help to support lifestyle changes which are needed for continued weight loss. Medically supervised fasts are very low calorie diets which provide from 400 to 800 calories per day. While most of these diets are low in calories, the protein provision is very high. The purpose of these diets is to promote fat loss, not muscle loss. The high protein content helps prevent large losses of muscle tissue. Electrolytes, vitamins and minerals are also supplemented. To achieve lasting weight loss, commitment must be given to making real changes in eating patterns. Individuals are who not committed will gain back their weight. During a binge, 10,000 to 20,000 calories can be consumed throughout the day. Binges usually consist of foods like cookies, candy, chips, ice cream and many other high calorie foods. Binges are often done in secret. After a binge, many of the feelings that caused the binge, like stress, may have subsided only to be replaced with feelings of guilt and lack of self-control. Binge eating is like bulimia, but does not include purging behaviors. A diagnosis of binge-eating disorder is made when a person binges an average of two days per week over a six month period.
The medications most often used in the management of obesity are commonly known as "appetite suppressant" medications. Appetite suppressant medications promote weight loss by increasing metabolism and by decreasing appetite or increasing the feeling of being full. These medications work by increasing the serotonin and/or catecholamine - two brain chemicals that affect mood, appetite and metabolism. Appetite suppressant medications help weight loss by diminishing appetite or increasing the feeling of being full. These medications diminish appetite by rising serotonin or catecholamine two brain chemicals that affect appetite. Appetite suppressant medications are used with a course of behavioral treatment and dietary counseling, designed to help you make long-term changes in your diet and physical activity. The most recent drug in the fight against obesity is Xenical. A new class of non-systemic anti-obesity drug called lipase inhibitors which act in the gastrointestinal tract to prevent the absorption of fat by about 30 percent. Drugs in this class do not achieve their effect through brain chemistry or central nervous system stimulation. In other words, Xenical is not an appetite suppressant or metabolic inducer. Over the short term, weight loss in obese individuals may reduce a number of health risks. Studies looking at the effects of appetite suppressant medication treatment on obesity-related health risks have found that some agents lower blood pressure, blood cholesterol, triglycerides (fats) and decrease insulin resistance (the body's inability to use blood sugar) over the short term. Long-term studies are currently being done to determine if weight loss from appetite suppressant medications can improve health. When considering long-term appetite suppressant medication treatment for obesity, you should consider the following areas of concern and potential risks. Currently, all prescription medications to treat obesity are controlled substances, meaning doctors need to follow certain restrictions when prescribing appetite suppressant medications. Although abuse and dependence are not common with non-amphetamine appetite suppressant medications, doctors should be cautious when they prescribe these medications for patients with a history of alcohol or other drug abuse. Most studies of appetite suppressant medications show that a patient's weight tends to level off after four to six months while still on medication treatment. While some patients and physicians may be concerned that this shows tolerance to the medications, the leveling off may mean that the medication has reached its limit of effectiveness. Based on the currently available studies, it is not clear if weight gain with continuing treatment is due to drug tolerance. Obesity often is viewed as the result of a lack of willpower, weakness, or a lifestyle "choice" - the choice to overeat and under exercise. The belief that persons choose to be obese adds to the hesitation of health professionals and patients to accept the use of long-term appetite suppressant medication treatment to manage obesity.
Body composition describes the percentages of fat, muscle and bone in your body. Many experts think men's bodies should be between 12 to 18 percent fat, while women's should be 18 to 22 percent fat. The risk of developing weight associated medical problems increases if the majority of body fat is located in the abdominal area. This risk decreases if body fat is primarily located in the hips, buttock and thigh region. Height and weight tables are generally used to determine how person's weight compares to a standard. However, weight in these tables is an overall measure of all components of the body. Individuals may differ in muscle, frame size and percentage of body fat. The waist to hip ratio of body composition assessment provides information on where the majority of body fat is located.
Definitions used on this pageFDA
- Food and Drug Administration: A government agency that oversees public safety in relation to drugs and medical devices. The FDA gives approval to pharmaceutical companies for commercial marketing of their products.
Fat blocker
- Drugs that block the absorption of fat or calories, and lose substantial weight.
Overweight
- Weighing more than is normal, necessary, or allowed, especially having more body weight than is considered normal or healthy for one's age or build.
Appetite
- An instinctive physical desire, especially one for food or drink. Decreased desire to eat is termed anorexia, while polyphagia (or "hyperphagia") is increased eating. Disregulation of appetite contributes to anorexia nervosa and cachexia, or oppositely, overeating.
Diabetes
- Any of several metabolic disorders marked by excessive discharge of urine and persistent thirst, especially one of the two types of diabetes mellitus.
Diet
- A regulated selection of foods, as for medical reasons or cosmetic weight loss.
- A solutions designed to reduce or suppress the appetite.
Fat
- Any of various soft, solid, or semisolid organic compounds constituting the esters of glycerol and fatty acids and their associated organic groups.
Obesity
- The condition of being obese; increased body weight caused by excessive accumulation of fat.
Stress
- A state of extreme difficulty, pressure, or strain.
- A physical and psychological response that results from being exposed to a demand or pressure.
Suppress
- To curtail or prohibit the activities of.
- To inhibit the expression of (an impulse, for example).
- To bring to an end forcibly as if by imposing a heavy weight.
|
